Beacon Biosignals
PrivateLast Round
Series C
Jun 9, 2026
Est. Valuation
$286.85M
Total Funding Raised
$366M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Beacon Biosignals is a healthcare technology company that provides an artificial intelligence-driven EEG analysis and diagnosis platform to accelerate drug development and improve brain health outcomes.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Medical AI, Medical Devices, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Hardware Sales, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Beacon Biosignals Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Beacon Biosignals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jun 9, 2026 | ||||
| Series B Extension | Apr 6, 2026 | ||||
| Series B | Nov 13, 2025 | ||||
| Series A | Nov 8, 2021 | ||||
| Seed | May 30, 2019 | ||||
Seed | May 1, 2019 |
Key People
Founding team and executive leadership
Beacon Biosignals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| S32 | Series B |
| Kicker Ventures | Series B, Series B Extension |
| GV | Series B Extension, Series B |
| JSL Health Capital | Series B, Series B Extension |
| Nexus NeuroTech Ventures | Series B, Series B Extension |
| Innoviva | Series B Extension, Series B |
| Catalio Capital Management | Series B, Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 9, 2026
$225M round led by General Catalyst and HarbourVest Partners.
- Apr 20, 2026
Attending the 2026 American Academy of Neurology Annual Meeting.
Beacon Biosignals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Beacon Biosignals's valuation, stock price, and market status.